Abstract
Cells of Candida albicans plated on media containing nalidixic acid (Nal) either die, adapt physiologically to Nal-tolerance or mutate to Nal-resistance. The fraction of a population exhibiting each response depends on the growth phase of cells when plated and their nitrogen and carbon nutrition and growth temperatures before and after plating. Nal induces Nal-resistant mutants in very high frequency but only at 37 C on plates containing i) glucose as primary carbon source and ii) adenine, a sulfur amino acid or a representative of the glutamic acid family of amino acids. Nal does not affect either forward mutation to caffeine-resistance or reverse mutation from histidine auxotrophy to prototrophy. Nal-resistant mutants produce minute colonies on Nal-free medium, respire oxidatively and are unusually sensitive to inhibitors of oxidative phosphorylation. They revert spontaneously to wild type at very high rates but can be propagated indefinitely in the absence of Nal by serial selection and replating of minute colonies. Cellular inactivation and induction of Nal-resistant mutants are greatly affected by specific inhibitors of mitochondrial macromolecular syntheses. The presence of chloramphenicol or erythromycin during exposure to Nal prevents cell death and mutation but has no effect on adaptation to Nal-tolerance. Growth on acriflavin or ethidium bromide enhances resistance of cells to inactivation when subsequently plated on Nal containing media. It is concluded that Nal-induced cellular inactivation and mutation to Nal-resistance, but not adaptation to Nal-tolerance, result from damages to the mitochondrion which are fixed or promoted by macromolecular syntheses within the mitochondrion. Implications of these findings for the therapeutic use of Nal are discussed.
Similar content being viewed by others
References
Bandlow, W. & F. Kandewitz. 1974. Action of ethidium bromide on mitochondrial DNA in the petite-negative yeast Schizosaccharomyces pombe. Molec. Gen. Genet. 131: 333–338.
Busbee, D.L. & A. Sarachek. 1969. Inactivation of Candida albicans by ultraviolet radiation. Arch. Microbiol. 64: 289–314.
Carnevali, F., L.E. Sarcoe & P.A. Whittaker. 1976. Differential effects of nalidixate on the cell growth of respiratory competent strains and cytoplasmic petite mutants of Saccharomyces cerevisiae. Molec. gen. Genet. 146: 95–100.
Chao, L. 1977. Nalidixic acid-induced protein alterations in Escherichia coli. Antimicrob. Agents Chemother. 11: 167–170.
Cook, T.M., K.G. Brown, I.V. Royle & W. A. Goss. 1966 Bacteriocidal action of nahoicix acid on Bacillus subtilis. J. Bacteriol., 92: 1510–1514.
Crumplin, G.C. & J.T. Smith. 1975. Nalidixic acid: an antibacterial paradox. Antimicrob. Agents Chemother. 8: 251–261.
deCastro, J.F., J.F.O. Carvalho, N. Moussatche & F.T. deCastro. 1975. Nalidixic acid macromolecular metabolism in Tetrahymena pyriformis: effects on protein synthesis. Antimicrob. Agents Chemother. 7: 487–493.
Fukuhara, H. and C. Kujawa. 1970. Selective inhibition of the in vivo transcription of mitochondrial DNA by ethidium bromide and by acriflavin. Biochem. Biophys. Res. Commun. 41: 1002–1008.
Gellert, M., K. Mizuuchi, M. O'Dea, T. Itoh & J. Tomizawa. 1977. Nalidixic acid resistance: a second genetic character involved in DNA gyrase activity. Proc. Natl. Acad. Sci. (USA) 74: 4772–4776.
Germond, J.E., B. Hirt, P. Oudet, M. Gross-Bellard & P. Chambon. 1975. Folding of the DNA double helix in chromatin-like structures from simian virus 40. Proc. Natl. Acad. Sci (USA) 72: 1843–1847.
Grivell, L.A. & V. Metz. 1973. Inhibition by ethidium bromide of mitochondrial protein synthesis programmed by imported poly (u). Biochem. Biophys. Res. Commun. 55: 125–131.
Gross, F.J. & D.G. Smith. 1972. The effect of nalidixic acid on growth and petite formation in Saccharomyces cerevisiae. Microbiol. 6: 139–146.
Gross, W.A. 1969. Nalidixic Acid: biological prolife. Urol. Panam. 1: 103–122.
Hamilton, P.B., D. Rosi, G.P. Peruzzotti & E.D. Neilson. 1969. Microbiological metabolism of naphthyridines. Appl. Microbiol. 17: 237–241.
Helling, R.B. & J.S. Kukora. 1971. Nalidixic acid-resistant mutants of Escherichia coli deficient in isocitrate dehydrogenase. J. Bacteriol. 105: 1224–1226.
Huede, M. & R. Chanet. 1975. Protein synthesis and the recovery of both survival and cytoplasmic ‘petite’ mutation in ultraviolet-treated yeast cells. II. Mitochondrial protein synthesis. Mutation Res. 28: 47–55.
Kot, E.J., V.L. Olson, L.J. Rolewic & D.O. McClary. 1976. An alternate pathway in Candida albicans. Antonie van Leeuwenhoek 42: 33–48.
Lakshmi, T.J. & R.B. Helling. 1976. Selection for citrate synthetase deficiency in icd mutants of Escherichia coli. J. Bacteriol. 127: 76–83.
Linnane, A.W., J.M. Haslam, H.B. Lukins & P. Nagley. 1972. The biogenesis of mitochondria in microorganisms. Ann. Rev. Microbiol. 26: 163–198.
Luha, A.A., L.E. Sarcoe & P.A. Whittaker. 1971. Biosynthesis of yeast mitochondria. Drug effects on the petite negative yeast Kluyveromyces lactis. Biochem. Biophys. Res. Commun. 44: 396–402.
Luria, S.E. & M. Delbruck. 1943. Mutations of bacteria from virus sensitivity to virus resistance. Genetics 28: 491–511.
Lyman, H. 1967. Specific inhibition of chloroplast replication in Euglena gracilis by nalidixic acid. J. Cell. Biol. 35: 726–730.
Mahler, H.R., C. Perlman, C. Henson & C. Weber. 1968. Selective effects of chloramphenicol, cyclohexamide and nalidixic acid on the biosynthesis of respiratory enzymes in yeast. Biochem. Biophys. Res. Commun. 31: 474–480.
McChesney, E.W., E.J. Froelich, G.Y. Lesher, A.V.R. Crain & D. Rosi. 1964. Absorption excretion and metabolism of a new antibacterial agent nalidixic acid. Toxicology and Applied Pharmacology 6: 282–209.
Michels, C.A., J. Blamire, B. Goldfinger & J. Marmur. 1973. Studies on the action of nalidixic acid in the yeast Saccharomyces cerevisiae. Antimicrob. Agents Chemother. 3: 562–567.
Nagai, S., N. Yanagishima & H. Nagai. 1961. Advances in the study of respiration-deficient (RD) mutation in yeast and other microorganisms. Bact. Rev. 25: 404–426.
Ogur, F., R. St. John & S. Nagai. 1957. Tetrazolium overlay technique for population studies of respiration deficiency in yeast. Science 125: 928–929.
Pienkos, P., A. Walfield & C.L. Hershberger. 1974. Effect of nalidixic acid on Euglena gracilis: induced loss of chloroplast deoxyribonucleic acid. Arch. Biochem. Biophys. 165: 548–553.
Puga, A. & I. Tessman. 1973. Mechanism of transcription of bacteriophage S 13 II. Inhibition of phage-specific transcription by nalidixic acid. J. Mol. Biol. 75: 99–108.
Robreau, G., G. Jensen & Y. LeGal. 1973. Isolement de mutants reistants a l'acide nalidixique Chez Chlamydomonas reinhardtii. C.R. Acad. Sci. Paris 277: 1699–1702.
Sarachek, A., R.V. Goering & J.T. Bish. 1969. Differential effects of growth temperature on inactivation and mutation of Candida albicans by ultraviolet radiation. Arch. Microbiol. 67: 189–198.
Schatz, G., G.S. Groot, T. Mason, W. Rouslin, D.C. Wharton & J. Salitzgaber. 1972. Biogenesis of mitochondrial inner membranes in bakers yeast. Fed. Proc. 31: 21–29.
Sherman, F. & P.P. Slonimski. 1964. Respiration-deficient mutants of yeast. II. Biochemistry. Biochim. Biophys. Acta. 90: 1–15.
Shuman, H. & M. Schwartz. 1975. The effect of nalidixic acid on the expression of some genes in Escherichia coli K-12. Biochem. Biophys. Res. Commun. 64: 204–209.
Sobieski, R.J. & A.R. Brewer. 1976. Toxicity of nalidixic acid on Candida albicans, Saccharomyces cerevisiae and Klyveromyces lactis. Antimicrob. Agents Chemother. 9: 485–492.
Sugino, A., C.L. Peebles, K.N. Kreuzer & N.R. Cozzarelli. 1977. Mechanism of action of nalidixic acid: purification of Escherichia coli nal A gene product and its relationship to DNA gyrase and a novel nicking-closing enzyme. Proc. Acad. Sci. (USA) 74: 4767–4771.
Vigier, P.R. 1974. Effet mutagene de l'acide nalidixique sur le bacteriophage T4. Mutation Res. 25: 25–32.
Wehr, C.T., R.D. Kudrna & L.W. Parks. 1970. Effect of putative deoxyribonucleic acid inhibitors on macro-molecular synthesis in Saccharomyces cerevisiae. J. Bacteriol. 102: 636–641.
Whittaker, P.A., R.C. Hammond & A.A. Luha. 1972. Mechanism of mitochondrial mutation in yeast. Nature, New Biology 238: 266–268.
Yamabe, S. 1976. Cytochrome c reduction by nalidixic and piromidic acids. J. of Antimicrobial Chemotherapy 2: 299–305.
Yamabe, S. 1978. The effect of nalidixic acid group compounds on reduction of cytochrome c from horse heart and Candida krusei. J. Gen. Microbiol. 105: 227–232.
Yamabe, S. & M. Shimizu. 1977. Combination effects of chemotherapeutic agents: I. Antagonistic effects of 1,10 phenanthroline with nalidixic acid and piromidic acid on the growth of Escherichia coli. J. of Antimicrobial Chemotherapy 3: 101–104.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Sarachek, A. Population changes induced in Candida albicans by nalidixic acid. Mycopathologia 68, 105–120 (1979). https://doi.org/10.1007/BF00441090
Issue Date:
DOI: https://doi.org/10.1007/BF00441090